Personalis, Inc

NASDAQ:  PSNL

Size:  $115mm

Bookrunners:  MS | BAML | COWEN

Co-managers: OPP

Major Holders:  Lightspeed Venture Partners | Abingworth Bioventures | MDV | Leland Stanford Junior University | John West (CEO)

Description:  Personalis is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response.

Note:  Emerging Growth Company

Reference Link:  S-1